The President and CEO of PPTA visits the Bolognana plant
The meeting was a valuable opportunity for Kedrion and PPTA to strengthen our ongoing partnership
Kedrion awarded national tender for Portuguese plasma manufacturing
First shipments of plasma from Porto and Lisbon were received in the beginning of February
World Hemophilia Day: Kedrion’s commitment
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
Kedrion-Pharmacosmos partnership for the treatment of Anemia in Italy
Exclusive agreement signed for the distribution of a novel iron-based therapy
Results of the “Words in Hemophilia: Towards Patient Engagement” study have been published
The project supported by Kedrion defines some of the key principles intended to improve patient envolvement
Kedrion and LFB sign industrial cooperation agreement
Scope is supplying Immunoglobulins to meet patient demand in France
Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
KIDCARES10, First Patient Treated in Pediatric PI Study
Thirty patients aged 2 to 17yo to be enrolled over five European countries
Kedrion stronger in North America and further committed to rare diseases
Agreement with Canadian-based Liminal BioSciences signed on June 22nd